Naturally, the body produces antibodies that help it fight infection. However, the body is not designed to build potent antibodies to fight viruses like SARS-CoV-2, the prevalent virus that causes COVID-19. This is so, especially for people who haven’t been infected with COVID-19 or received the vaccine yet.
The body needs monoclonal antibodies to help prevent COVID-19 infection from the body’s immune system. These monoclonal antibodies, also known as mAbs, are laboratory-made proteins directly infused into the body to fight off SARS-CoV-2.
Monoclonal antibody infusion therapy in Arizona is different from taking the COVID-19 vaccine. While monoclonal antibody therapy is helpful to anyone who has a higher chance of developing severe COVID-19 symptoms, the COVID-19 vaccine is used to trigger a natural response from the body’s immune system.
There are several benefits of monoclonal antibody therapy in Arizona, including the following;
- This therapy is used to treat people infected with the COVID-19 virus.
- It is used to treat people developing symptoms or who have higher chances of developing severe COVID-19 symptoms.
- It minimizes viral loads and hospitalization and reduces the severity of COVID-19 symptoms.
- Under the Emergency Use Authorization (EUA), monoclonal antibody therapy is used as an emergency treatment for people between the age of 12 and above.
Who Is Qualified for Monoclonal Antibody Therapy in Arizona?
It needs to be given early for monoclonal antibody therapy for COVID-19 to be effective. The monoclonal antibody therapy is ineffective for anyone hospitalized or seriously infected with the COVID-19 virus. It is important to note that this therapy does not prevent people infected with COVID-19 from being hospitalized, which is why people should get vaccinated and wear masks.
While everyone is encouraged to be vaccinated for SARS-CoV-2, not everyone is advised to get this therapy. This therapy does not replace the COVID-19 vaccine but is suitable for the following people.
- People who have higher chances of severely getting ill from the COVID-19 virus
- People who developed symptoms and tested positive for COVID-19 within ten days or less
- People between the ages of 12 and above weigh at least 88 pounds.
- People with underlying health conditions that may increase their chances of getting infected with the virus
We must list some factors that may cause high-risk exposure to the COVID-19 virus. These factors can be associated with the following;
- People who are overweight with a BMI above 25
- Pregnant women
- People with chronic kidney disease
- People with a weak immune system
- People undergoing immunosuppressive treatment
- People with hypertension or other cardiovascular diseases
- Sickle cell patients
- People with neurodevelopmental disorders
- Anyone with chronic lung diseases, etc.
How It Works
This antibody therapy relies on monoclonal antibodies similar to the natural antibodies the body produces to help fight infections. However, the monoclonal antibodies are made in the lab and designed to recognize a specific component of SARS-CoV-2 which is the protein spike on its outer shell.
The goal is to fight off this protein spike by interfering with the ability of the virus to attach itself and gain entry into the human cell. This, therefore, keeps the immune system alert until it can function and react independently.
Over time monoclonal antibody infusion therapy in Arizona has proven to be effective but insufficient to replace the need for vaccination. Citizens are still advised to get vaccinated so they can ultimately end the spread of the COVID-19 virus.
Like every other treatment, there are possible side effects from monoclonal antibody infusion therapy in Arizona. However, because researchers are still studying this therapy, it is impossible to ascertain its entire risk yet. The possible side effect of COVID-19 includes the following;
- It may intrude on the ability of the body to prevent COVID-19 infection in the future.
- The body’s immune response to the COVID-19 vaccine may be affected negatively, i.e., it may be reduced.
- The main side effect of monoclonal antibody therapy in Arizona is that it can cause allergic reactions. These reactions may include fever, headache, nausea, low blood pressure, shortness of breath, facial swelling, itchiness, etc. When these symptoms occur, it is advisable to contact your doctor immediately.
Your doctor must decide if you qualify for monoclonal antibody therapy in Arizona because not everyone qualifies for it. This treatment does not replace the need to get vaccinated and is unsuitable for people who already experience severe symptoms of COVID-19.